Short answer: Phentermine and semaglutide work differently. Phentermine is a stimulant-like pill approved for short-term weight loss. Wegovy is a semaglutide product approved for long-term weight management in eligible patients. Neither is right for everyone. The choice depends on health history, side effects, goals, and cost.
For weight-loss treatment, adults may qualify with a body mass index (BMI) of 30 or more, or 27 or more plus a weight-related condition. BMI compares weight with height. Meeting that threshold does not guarantee that either medicine is safe for you. Your clinician must check heart health, other medicines, and pregnancy plans.
| Feature | Phentermine alone | Semaglutide (Wegovy) |
|---|---|---|
| How it works | Stimulant-like appetite medicine | Acts on the GLP-1 hormone pathway |
| Approved duration | Short term: a few weeks | Long-term weight management |
| How it is taken | By mouth, as prescribed | Weekly injection or daily tablet; directions differ |
| Common concerns | Dry mouth, poor sleep, pulse and blood-pressure changes | Nausea, vomiting, diarrhea, constipation |
1. They use different mechanisms
Phentermine stimulates the nervous system and can reduce appetite. It may also raise heart rate or blood pressure and make sleep harder.
Semaglutide acts on the GLP-1 hormone pathway to reduce appetite and food intake. It also slows stomach emptying. It does not work like a stimulant.
2. Their approved treatment duration differs
Phentermine alone is approved for a few weeks alongside changes in food, activity, and habits. Wegovy is approved for ongoing weight management when it remains helpful and safe. Phentermine/topiramate, sold as Qsymia, is a different combination medicine with a long-term indication.
Some clinicians use phentermine alone longer than its label describes. That is off-label. Ask why it is being recommended, what evidence supports it, and how risks will be monitored.
3. Dosing and administration are different
Phentermine is taken by mouth; timing depends on the prescription. Late doses may disturb sleep. Wegovy injections are taken weekly and increased slowly. Wegovy tablets are taken daily with different food and water instructions. Do not copy one product’s schedule onto another.
Patients should not substitute one semaglutide product for another or combine weight-loss medicines without prescriber direction.
4. Common side effects are not the same
Phentermine can cause dry mouth, poor sleep, restlessness, constipation, or a pounding heartbeat. Blood pressure can rise too. Semaglutide can cause nausea, diarrhea, vomiting, constipation, belly pain, or indigestion.
Lasting or severe symptoms need medical review. Our guide to phentermine care in Texas explains screening. Our GLP-1 side-effects guide covers common symptoms and warning signs.
5. Who should avoid each medicine?
Do not use phentermine with a history of heart disease or stroke, uncontrolled high blood pressure, an overactive thyroid, glaucoma, severe agitation, or a history of drug abuse. It is also ruled out during pregnancy, breastfeeding, while taking an MAOI medicine, or within 14 days after one. An allergy to this type of stimulant also rules it out.
Wegovy should not be used with a personal or family history of medullary thyroid cancer, a rare thyroid cancer, or the inherited condition MEN 2. It also should not be used after a serious allergy to semaglutide. Its thyroid-tumor warning is based on animal findings; human risk is unknown. It is not used for weight loss during pregnancy.
Other risks include pancreas inflammation, gallbladder problems, dehydration that can harm the kidneys, and severe stomach problems. Wegovy is not recommended with severe gastroparesis, a condition that slows stomach emptying. Review all warnings with your clinician.
6. Monitoring reflects each medication’s risks
With phentermine, follow-up often checks blood pressure, pulse, sleep, anxiety, and whether the dose still helps. With semaglutide, it often checks stomach symptoms, fluid intake, dose changes, and blood sugar if you have diabetes.
Both require review of other medications and health history before prescribing.
7. Average weight-loss evidence differs
Weekly semaglutide 2.4 mg has large, long-term weight-loss trials. Phentermine alone has a shorter approval period and a different evidence base. Studies using the same patients, length of treatment, and support program are limited, so separate trial averages are not a fair head-to-head comparison.
Population averages cannot predict an individual result. Access to a medication does not guarantee a specific percentage of weight loss.
8. The right choice may be neither
Some people cannot safely use either medicine. Another approved medicine, a food and activity program, or surgery may fit better. A clinician may also need to treat a health problem that contributes to weight gain. Cost and coverage matter too.
Before treatment, ask whether you qualify, what other options you have, and how progress will be measured. Also ask when side effects or lack of benefit would mean changing or stopping the plan.
Frequently asked questions
Is phentermine stronger than semaglutide?
“Stronger” is not a useful medical comparison. They work differently and have different evidence, risks, and approved durations.
Can phentermine and semaglutide be taken together?
Do not combine them on your own. Phentermine labeling does not recommend adding other weight-loss medicines. A prescriber must review the evidence, heart risks, side effects, and all other medicines before considering an off-label combination.
Which option is better for long-term treatment?
Wegovy is approved for long-term weight management. Phentermine alone is approved for short-term use. Your health history still decides whether either fits.
Do both require a prescription?
Yes. Both require a prescription and should be used with clinical monitoring.
This comparison gives general information. It is not a prescription or a personal treatment recommendation.
